Literature DB >> 16729224

Interaction of ibuprofen and other structurally related NSAIDs with the sodium-coupled monocarboxylate transporter SMCT1 (SLC5A8).

Shirou Itagaki1, Elangovan Gopal, Lina Zhuang, You-Jun Fei, Seiji Miyauchi, Puttur D Prasad, Vadivel Ganapathy.   

Abstract

PURPOSE: Sodium-coupled monocarboxylate transporter 1 (SMCT1) is a Na+-coupled transporter for monocarboxylates. Many nonsteroidal anti-inflammatory drugs (NSAIDs) are monocarboxylates. Therefore, we investigated the interaction of these drugs with human SMCT1 (hSMCT1).
METHODS: We expressed hSMCT1 in a mammalian cell line and in Xenopus laevis oocytes and used the uptake of nicotinate and propionate-induced currents to monitor its transport function, respectively. We also used [14C]-nicotinate and [3H]-ibuprofen for direct measurements of uptake in oocytes.
RESULTS: In mammalian cells, hSMCT1-mediated nicotinate uptake was inhibited by ibuprofen and other structurally related NSAIDs. The inhibition was Na+ dependent. With ibuprofen, the concentration necessary for 50% inhibition was 64 +/- 16 microM. In oocytes, the transport function of hSMCT1 was associated with inward currents in the presence of propionate. Under identical conditions, ibuprofen and other structurally related NSAIDs failed to induce inward currents. However, these compounds blocked propionate-induced currents. With ibuprofen, the blockade was dose dependent, Na+ dependent, and competitive. However, there was no uptake of [3H]-ibuprofen into oocytes expressing hSMCT1, although the uptake of [14C]-nicotinate was demonstrable under identical conditions.
CONCLUSIONS: Ibuprofen and other structurally related NSAIDs interact with hSMCT1 as blockers of its transport function rather than as its transportable substrates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729224     DOI: 10.1007/s11095-006-0023-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  24 in total

Review 1.  Role of transporters in placental transfer of drugs.

Authors:  Vadivel Ganapathy; Puttur D Prasad
Journal:  Toxicol Appl Pharmacol       Date:  2005-09-01       Impact factor: 4.219

2.  Role of monocarboxylic acid transporters in the cellular uptake of NSAIDs.

Authors:  Jun-Shik Choi; Ming Ji Jin; Hyo-Kyung Han
Journal:  J Pharm Pharmacol       Date:  2005-09       Impact factor: 3.765

Review 3.  Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.

Authors:  P B Mortensen; M R Clausen
Journal:  Scand J Gastroenterol Suppl       Date:  1996

Review 4.  Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.

Authors:  D Pereg; M Lishner
Journal:  J Intern Med       Date:  2005-08       Impact factor: 8.989

5.  Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration.

Authors:  A Rubin; B E Rodda; P Warrick; A S Ridolfo; C M Gruber
Journal:  J Pharm Sci       Date:  1972-05       Impact factor: 3.534

Review 6.  New perspectives on the use of niacin in the treatment of lipid disorders.

Authors:  James McKenney
Journal:  Arch Intern Med       Date:  2004-04-12

Review 7.  Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications.

Authors:  O C Velázquez; H M Lederer; J L Rombeau
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

8.  The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter.

Authors:  Michael J Coady; Min-Hwang Chang; Francois M Charron; Consuelo Plata; Bernadette Wallendorff; Jerome Frank Sah; Sanford D Markowitz; Michael F Romero; Jean-Yves Lapointe
Journal:  J Physiol       Date:  2004-04-16       Impact factor: 5.182

9.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.

Authors:  Hui Li; Lois Myeroff; Dominic Smiraglia; Michael F Romero; Theresa P Pretlow; Lakshmi Kasturi; James Lutterbaugh; Ronald M Rerko; Graham Casey; Jean-Pierre Issa; Joseph Willis; James K V Willson; Christoph Plass; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

10.  Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids.

Authors:  I Tamai; H Takanaga; H Maeda; Y Sai; T Ogihara; H Higashida; A Tsuji
Journal:  Biochem Biophys Res Commun       Date:  1995-09-14       Impact factor: 3.575

View more
  19 in total

1.  Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.

Authors:  Diana Højmark Omkvist; Birger Brodin; Carsten Uhd Nielsen
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: a RPE specific phenomenon.

Authors:  Sudha Ananth; Lina Zhuang; Elangovan Gopal; Shiro Itagaki; Babu Ellappan; Sylvia B Smith; Vadivel Ganapathy; Pamela Martin
Journal:  Biochem Biophys Res Commun       Date:  2010-02-21       Impact factor: 3.575

3.  Characterization of butyrate uptake by nontransformed intestinal epithelial cell lines.

Authors:  Pedro Gonçalves; João R Araújo; Fátima Martel
Journal:  J Membr Biol       Date:  2011-02-01       Impact factor: 1.843

4.  Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate.

Authors:  Muthusamy Thangaraju; Senthil K Karunakaran; Shiro Itagaki; Elangovan Gopal; Selvakumar Elangovan; Puttur D Prasad; Vadivel Ganapathy
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

5.  Insulin and SGK1 reduce the function of Na+/monocarboxylate transporter 1 (SMCT1/SLC5A8).

Authors:  Adriana López-Barradas; Tania González-Cid; Norma Vázquez; Marisol Gavi-Maza; Adriana Reyes-Camacho; Laura A Velázquez-Villegas; Victoria Ramírez; Kambiz Zandi-Nejad; David B Mount; Nimbe Torres; Armando R Tovar; Michael F Romero; Gerardo Gamba; Consuelo Plata
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

6.  Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.

Authors:  Elangovan Gopal; Seiji Miyauchi; Pamela M Martin; Sudha Ananth; Penny Roon; Sylvia B Smith; Vadivel Ganapathy
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 7.  Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis.

Authors:  Sathish Sivaprakasam; Yangzom D Bhutia; Shengping Yang; Vadivel Ganapathy
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

8.  The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition.

Authors:  Dapeng Cui; Marilyn E Morris
Journal:  Drug Metab Dispos       Date:  2009-04-23       Impact factor: 3.922

Review 9.  Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Elangovan Gopal; Pamela M Martin; Shiro Itagaki; Seiji Miyauchi; Puttur D Prasad
Journal:  AAPS J       Date:  2008-04-02       Impact factor: 4.009

10.  Monocarboxylate transporter mediated uptake of moxifloxacin on human retinal pigmented epithelium cells.

Authors:  Megha Barot; Mitan R Gokulgandhi; Vibhuti Agrahari; Dhananjay Pal; Ashim K Mitra
Journal:  J Pharm Pharmacol       Date:  2013-09-01       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.